Poster Session B - Monday Morning
Category: Functional Bowel Disease
Allison Marshall, BS
Tufts Medical Center
Boston, MA
Demographics | Pre-legalization (n=12 patients) | Post-legalization(n=51patients) | p-val |
Number of hospital admissions | 15 | 57 | NA |
Female gender n, (frequency) | 4 (33.3) | 29 (50.9) | 0.25 |
Age mean, (st dev) | 35.5 (11.5) | 32.9 (13.5) | 0.32 |
Cannabis type used n, (frequency) | |||
Smoking | 6 (50.0) | 31 (60.8) | 0.53 |
Vaping | 0 | 2 (3.9) | - |
Edibles | 0 | 2 (3.9) | - |
More than one type | 0 | 1 (2.0) | - |
Not reported | 6 (50.0) | 15 (29.4) | - |
Cannabis use frequency n, (frequency) | |||
Less than daily | 0 | 9 (17.6) | 0.19 |
At least daily | 3 (25.0) | 24 (47.1) | 0.21 |
Multiple times daily | 3 (25.0) | 8 (15.7) | 0.42 |
Unknown | 6 (50.0) | 10 (19.6) | - |
Utilization of Services | Pre-legalization (n=15 hospitalizations) | Post-legalization (n=57 hospitalizations) | p-val |
Length of inpatient stay, days median, (IQR) | 1.0 (1.0-2.0) | 3.0 (1.0-4.0) | < 0.005 |
Cannabis urine screen positivity n, (frequency) | 10 (66.7) | 37 (64.9) | 1.0 |
Cannabis urine screen not performed n, (frequency) | 4 (26.7) | 16 (28.1) | 1.0 |
Basic metabolic panel, days median, (IQR) | 2 (1.0-2.8) | 2.0 (0.25-3.0) | 0.79 |
Antiemetics, days median, (IQR) | 1.0 (1.0-2.5) | 3.0 (2.0-4.0) | < 0.05 |
Intravenous fluids, days median, (IQR) | 1.0 (1.0-2.0) | 1.0 (1.0-2.0) | 0.32 |
Endoscopies performed n, (frequency) | 3.0 (20.0) | 14.0 (24.5) | 1.00 |
Imaging studies performed n, (frequency) | 12.0 (80.0) | 43.0 (75.4) | 1.00 |
GI consults n, (frequency) | 5.0 (33.3) | 26.0 (45.6) | 0.57 |
ICU-level care needed days median, (IQR) | 0.0 | 9.0 (15.8) | 0.19 |
Cost of Services | Pre-legalization (n=15 hospitalizations) | Post-legalization (n=57 hospitalizations) | p-val |
Mean inpatient charge | $7460 | $18,714 | < 0.0005 |
IVF charges, mean | $551 | $745 | < 0.05 |
Endoscopy charges, mean | $1512 | $2360 | < 0.05 |